HeyJaredBob Woods
- Indexed articles, last 90 days
- 2
- Latest publication
- Aug 15, 2026
- Outlet visibility, for CNBC
- Top 5K sites
- Earliest in this view
- Jul 19, 2026
Latest articles
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle (opens the original)
Read excerpt
Marijuana has had a history of highs and lows in the U.S. over the past century â legally, politically and culturally â teetering between vilification and acceptance. Since 1996, 40 states and the District of Columbia have legalized either medical or recreational adult-use marijuana. Yet cannabis, the leafy plant from which marijuana is derived, is still a federally illegal Schedule I drug as defined by the 1970 Controlled Substances Act. Â With November's pivotal midterm elections fast appr
The market for psychedelic drugs to treat mental health conditions gets a big buy signal (opens the original)
Read excerpt
Thursday's announcement that Eli Lilly will acquire AtaiBeckley, a clinical-stage maker of psychedelic drugs, for up to $3.8 billion indicates Big Pharma's increasing embrace of a long-stigmatized class of medications as alternatives for treating an array of mental health conditions. The news comes on the heels of positive clinical trial results of several different psychedelics, as well as President Trump's executive order in April fast-tracking reviews of such drugs by the Food and Drug Admini
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5K sites
For CNBC, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.